
Biocon gains after Health Canada nod for cancer, osteoporosis drugs
Biocon shares rise after Health Canada approves Bosaya and Vevzuo denosumab biosimilars for osteoporosis and cancer bone conditions, stock up about 1.5 percent at 364.40

Biocon shares rise after Health Canada approves Bosaya and Vevzuo denosumab biosimilars for osteoporosis and cancer bone conditions, stock up about 1.5 percent at 364.40

The Nifty India Defence Index is currently trading 1.3% higher, with stocks such as Data Patterns, Astra Microwave, Garden Reach Shipbuilders, MTAR Tech, trading with…

Gold and silver prices consolidate in a structural bull market, expert Renisha Chainani advises staggered buying and balanced gold silver allocation for investors.

HSBC strategist Max Kettner says Iran war fears are fading, S&P 500 and Nasdaq hit records, history supports quick rebounds, he stays strongly bullish on…

Nitin Aggarwal, Senior Group VP and Head of BFSI, Institutional Equities at Motilal Oswal Financial Services Limited (MOFSL) highlights stable asset quality, strong loan growth…

Macquarie believes the transaction appears strategically attractive, based on the complementary nature of the two companies’ portfolios and geographic presence.

Vedanta has the largest aluminium capacity in India which is more than 2.5 MT and is headed towards 3 MT. Therefore, the company gains on…

The Bank of Maharashtra management said that while growth will continue, it will not be at the cost of credit quality. The lender will focus…

In October 2024, Adani Enterprises had raised ₹4,200 crore through a QIP by issuing shares to Quant Mutual Fund, SBI Life Insurance and other eligible…

According to Citi, Groww has benefited from elevated market volatility, which has driven higher trading volumes in the broking segment.